L&C BIO Co.,LTD (KOSDAQ:290650)

South Korea flag South Korea · Delayed Price · Currency is KRW
85,300
-3,800 (-4.26%)
At close: Feb 6, 2026
278.27%
Market Cap2.12T +249.9%
Revenue (ttm)79.99B +19.4%
Net Income78.00B
EPS3,050.54
Shares Out24.84M
PE Ratio27.71
Forward PEn/a
Dividend50.00 (0.06%)
Ex-Dividend DateDec 29, 2025
Volume459,527
Average Volume664,250
Open86,500
Previous Close89,100
Day's Range84,500 - 88,800
52-Week Range18,490 - 97,500
Beta1.47
RSI64.62
Earnings DateFeb 13, 2026

About L&C BIO Co.,LTD

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine. The company offers pharmaceuticals, human tissue, medical device, and cosmetics products. L&C Bio Co., Ltd was founded in 2011 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 2011
Employees 141
Stock Exchange KOSDAQ
Ticker Symbol 290650
Full Company Profile

Financial Performance

In 2024, L&C BIO Co.,LTD's revenue was 72.09 billion, an increase of 9.35% compared to the previous year's 65.93 billion. Earnings were 141.06 billion, an increase of 191.69%.

Financial Statements